The weekly litigation news digest is live. Subscribe now

Botti patent opposition analysis

The comprehensive analysis of Botti opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Botti

Patent NumberTitleApplicantOpposition DateOpposition Company
Combination DrugCHUGAI SEIYAKU KABUSHIKI KAISHASep 24, 2025BOTTI & FERRARI
Combination Decitabine And Cedazuridine Solid Oral Dosage FormsOTSUKA PHARMACEUTICALJun 11, 2025BOTTI & FERRARI
Pharmaceutical Compositions Comprising A Jak InhibitorGALAPAGOSSep 17, 2024BOTTI & FERRARI
Method For Producing Mineral FibresSAINT GOBAINSep 6, 2024STM
Method For Processing A Structured Surface Of An Embossing ToolHUECK RHEINISCHEJul 11, 2024SESA
Combination Therapy For CopdCHIESI FARMACEUTICIJul 3, 2024BOTTI & FERRARI
Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALSJun 26, 2024BOTTI & FERRARI
Methods Of Using Pyruvate Kinase ActivatorsAGIOS PHARMACEUTICALSJun 11, 2024BOTTI & FERRARI
Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-SulfonamideAGIOS PHARMACEUTICALSMay 2, 2024BOTTI & FERRARI
Mash Filter MembraneHEINEKEN SUPPLY CHAINMar 7, 2024BOTTI & FERRARI

Top companies who are the clients of Botti